|
Evaluation of the immunogenicity and safety of a commercially available vaccine when co-administered with GlaxoSmithKline Biologicals' HPV vaccine (580299) in healthy female subjects. |
Human Papillomavirus Types 16 and 18 Vaccine |
111567 |
NCT00637195 2007-007876-41 |
Infections, Papillomavirus |
Phase 3 |
|
|
|
|
|
May 2013 |